About Cellatopia
Cellatopia is a Healthcare company based in Suzhou (China) founded in 2023 by Jingyu Li. It operates as a biomedical tools for cell reproducibility and reliability are developed. Its chief executive is Jingyu Li. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Cell Biology.
Company details
Cellatopia was founded in 2023 in Suzhou, China, within the biomedical sector. Tools are developed to support cell reproducibility and reliability. Solutions are provided for precise control of cell culture and processing systems. These are applied in research laboratories and clinical settings. Operations focus on enabling consistent outcomes in biomedical research and therapeutic applications.
- Headquarters Suzhou, China
- Founders Jingyu Li
- SectorsHealthcare
Funding Insights of Cellatopia
- Total Rounds 1
All 1 funding rounds of Cellatopia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2024 | – | Seed | – | – | – |
People of Cellatopia
1 people are tracked at Cellatopia (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jingyu Li | Founder & CEO | Leadership |
Complete people profiles for Cellatopia
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cellatopia
2 dated milestones of Cellatopia across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Cellatopia is founded.
- Funding First funding round.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Cellatopia (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cellatopia
Cellatopia was founded in 2023 and raised its 1st funding round 1 year after it was founded.
Cellatopia is headquartered in Suzhou, China. It is registered at Suzhou, Jiangsu, China.
Jingyu Li is the current CEO of Cellatopia. They have also founded this company.
Cellatopia was founded in 2023 in Suzhou, China, within the biomedical sector. Tools are developed to support cell reproducibility and reliability. Solutions are provided for precise control of cell culture and processing systems. These are applied in research laboratories and clinical settings. Operations focus on enabling consistent outcomes in biomedical research and therapeutic applications.